期刊文献+

人肝癌与肝正常细胞系ST3Gal唾液酸转移酶家族表达差异的研究 被引量:1

Study of the ST3Gal Family Expression between Hepatic Cell Line L-02 and Hepatoma Carcinoma Cell Line HepG-2 and SMMC-7721
下载PDF
导出
摘要 目的:分析ST3Gal唾液酸糖基转移酶家族在不同肝细胞系表达的差异,为ST3Gal唾液酸糖基转移酶家族与细胞膜唾液酸糖链表达相关性研究奠定基础。方法:采用实时荧光定量PCR技术检测人正常肝细胞系L-02、人肝癌细胞系HepG-2、SMMC-7721中ST3Gal唾液酸转移酶家族全部成员ST3GalⅠ~Ⅵ的mRNA表达情况。结果:与L-02相比,HepG-2、SMMC-7721中ST3GalⅣ高表达;ST3GalⅠ、ST3GalⅤ、ST3GalⅥ低表达;ST3GalⅡ、ST3GalⅢ不稳定表达。结论:高表达的ST3GalⅣ可能是调节细胞膜表面唾液酸糖链的关键酶之一,并与肝癌细胞膜表面α23-唾液酸糖链表达增高相关。 Objective: To analysis the differences of ST3Gal sialic acid glycosyltransferase expression between different hepatic cell lines, which was the foundation of the expression correlation study between sialic acid glycosyhransferases and cell membrane carbohydrate chains. Method: All members of ST3Gal sialic acid glycosyltransferaes family ST3Gal Ⅰ-Ⅵ expression on mRNA levels of L-02, HepG-2, SMMC-7721 cell lines were detected by Realtime PCR method. Result: Comparing with the hepatic cell line L- 02, ST3Gal Ⅳ highly expressed in the hepatoma cell lines HepG-2 and SMMC-7721, ST3Gal Ⅰ , ST3Gal Ⅴ, ST3GalⅥ lowly expressed, ST3Gal Ⅱ , ST3Gal Ⅲ were unstably expressed. Conclusion: Overexpresed ST3Gal IV may be one of the key enzyme to regulate the cell surface sialic acids, which participates in the increase of hepatoma cell membrane α2, 3-sialic acids.
出处 《沈阳医学院学报》 2013年第1期17-20,共4页 Journal of Shenyang Medical College
基金 沈阳医学院科技基金资助项目(No.20112052)
关键词 肝癌 唾液酸糖基转移酶 细胞系 hepatoma sialyhransferase cell line
  • 相关文献

参考文献16

  • 1Zhao YY, Takahashi M, Gu JG, et al. Functional roles of Nglycans in cell signaling and cell adhesion in cancer [ J ]. Cancer Sci, 2008, 99 (7): 1304-1310.
  • 2Fabio Dall'Olio, Mariella Chiricolo, Antonia D'Errico, et al. Ex- pression of 15-galactosidea2, 6 sialyltransferase and ofct2, 6-sialy- lated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis [J]. Glycobiology, 2004, 14 (1): 39-49.
  • 3Schattenberg JM, Galle PR. Cell Death and Hepatocarcinogene- sis : Dysregulation of apoptosis signaling pathways [ J ]. J Gastro- enterol Hepatol, 2011, 26 (1): 213-219.
  • 4Wang PH. Altered glycosylation in cancer: sialic acids and sialyl- transferases [J]. J Cancer Mol, 2005, 1 (2) : 73 -81.
  • 5Burda P, Aebi M. The dolichol pathway of N-linked glycosylation [J]. Biochem Biophys Acta, 1999, 1426 (59): 239-257.
  • 6Panlson JC, Colley KJ. Glycosyltransferases structure localization and control of cell type-specific glycosylation [ J ]. J Biol Chem, 1999, 264 (145) : 17615 -17618.
  • 7Malagolini N, Chiricolo M, Marini M. Exposure of or2, 6-sialy- lated lactosaminic chains marks apoptotic and necrotic death in dif- ferent celltypes [J]. Glycobiology, 2009, 19 (2): 172-181.
  • 8Moriwaki K, Noda K, Nakagawa T, et al. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation [ J ]. Glycobiology, 2007, 17 (12): 1311 -1320.
  • 9Takashima S. Characterization of mouse sialyhransferase genes: their evolution and diversity [ J ]. Biosci Biotechnol Biochem, 2008, 72 (5): 1155-1167.
  • 10Kornfeld S. Diseases of abnormal protein glycosylation : an emer- ging area [J]. J Clin Invest, 2001, 101 (78) : 1293 - 1295.

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部